Shares of Talis Biomedical Co. (NASDAQ:TLIS – Get Free Report) shot up 77.5% during trading on Friday . The stock traded as high as $2.84 and last traded at $2.84. 59,306 shares were traded during mid-day trading, an increase of 2,761% from the average session volume of 2,073 shares. The stock had previously closed at $1.60.
Talis Biomedical Price Performance
The stock has a 50-day moving average price of $2.02 and a two-hundred day moving average price of $1.67. The stock has a market cap of $5.18 million, a PE ratio of -0.10 and a beta of 1.32.
Talis Biomedical Company Profile
Talis Biomedical Corp is a molecular diagnostics company that develops point-of-care testing solutions for infectious diseases. The company’s technology leverages sample-to-answer automation to deliver rapid, lab-quality results outside of traditional laboratory settings. Talis Biomedical focuses on simplifying complex molecular assays to enable broader access in clinical laboratories, urgent care facilities and other decentralized testing environments.
The company’s flagship Talis One platform integrates proprietary reagents, single-use test cartridges and a compact analyzer to automate the workflow from extracted sample to result.
See Also
- Five stocks we like better than Talis Biomedical
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Do not delete, read immediately
- A U.S. “birthright” claim worth trillions – activated quietly
- First Time Since 2007: All Warnings Active
- Best $19 you’ll spend this year.
Receive News & Ratings for Talis Biomedical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Talis Biomedical and related companies with MarketBeat.com's FREE daily email newsletter.
